AnyplexII™ STI-12 Detection has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for detection of Candida albicans, Chlamydia trachomatis, Gardnerella vaginalis, Herpes simplex virus type 1, Herpes simplex virus type 2, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma parvum and Ureaplasma urealyticum.
Feb 13, 2020| Anyplex™Ⅱ STI-12 Detection
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ STI Essential Assay Q(MH,UU). This assays?is a multiplex real-time PCR assay to simultaneously detect 7 pathogens causing sexually transmitted infections. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct value or quantitative result of each pathogen in a single channel. The quantitative result of Mycoplasma hominis and Ureaplasma urealyticum helps effective management of STIs.
May 30, 2019| Allplex™ STI Essential Assay Q(MH,UU)
Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ Vaginitis Screening Assay. This assay is a Multiplex Real-time PCR assay that detects and identifies major pathogens related vaginitis simultaneously. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct values of each pathogen in a single channel. And it provides automated interpretation of BV using Seegene Viewer based on quantification information of major targets.
Jan 25, 2019| Allplex™ Vaginitis Screening Assay
Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ MG & AziR Assay. This assays?is a multiplex real-time PCR assay that detects and identifies?Mycoplasma genitalium?(MG) and 6 mutations causing azithromycin resistance. Azithromycin is generally prescribed for 1st-line treatment of MG. Based on Seegene’s proprietary DPO™ & MuDT™ Technology, this assay enables to check MG infection and azithromycin resistance in a single test and reports multiple Ct?values of each pathogen in a single tube.
Oct 29, 2018| Allplex™ MG & AziR Assay
Allplex™ Bacterial Vaginosis Assay simultaneously detects 7 bacteria (G. vaginalis, A. vaginae, Megasphaera type 1, BV-associated bacteria 2, Mobiluncus spp., B. fragilis, Lactobacillus spp.) associated with vaginosis. It provides quantitative information of 3 major bacteria (G. vaginalis, A. vaginae, Lactobacillus spp.). Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct value of multiple bacteria in a single channel. The CE-IVD mark will allow more opportunities for Seegene to market and sell within the European Union.
Dec 15, 2016| Allplex™ Bacterial Vaginosis Assay
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Genital ulcer Assay and Allplex™ Candidiasis Assay. Allplex™ Genital ulcer Assay detects 7 pathogens (HSV1, HSV2, CMV, VZV, LGV related CMV, T. pallidum, H. ducreyi ) causing genital ulcer simultaneously. Allplex™ Candidiasis Assay detects and differentiate 7 candida spp.(C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. lusitaniae, C. dubliniensis ) causing candidiasis simultaneously. Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report multiple Ct values of each pathogen in a single channel using real-time PCR instruments.The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Oct 14, 2016| Allplex™ Candidiasis Assay
Allplex™ STI Essential Assay is a multiplex real-time PCR test that can simultaneously detect seven of the more common causes of STIs from a wide range of specimen types including genital swab, urine and liquid based cytology specimen. The Allplex™ STI Essential Assay will provide clinicians with a powerful tool to help protect health and prevent the spread of STIs.
May 01, 2016| Allplex™ STI Essential Assay
Anyplex™ II STI-7 Detection Simultaneous detection of 7 STI causing pathogensAnyplex™ II STI-7 Detection detects 7 major STI causing pathogens in a single real-time PCR. Anyplex™ II STI-7 Detection enables the detection and differentiations of 7 major STI causative pathogens in a single real-time PCR reaction. The assay is based upon Seegene's proven DPO technology and its newly developed TOCE™ technology. A majority of Sexually Transmitted Infections (STI) can be asymptomatic and some have a high prevalence rate. If left untreated, they can become a major cause of diseases such as PID, extra uterine pregnancy, infertility, chronic pelvic pain, cervicitis and urethritis. Anyplex™ II STI-7 Detection is a test that not only prevents further spread of STIs but can also provide for effective STI treatments as it detects and differentiates the 7 major STI causative pathogens. Anyplex™ II STI-7 Detection is provided with on Internal control (STI-7 IC). This STI-7 IC enables the user can confirm the nucleic acid isolation and to check a possibility containig inhibitor.
Aug 31, 2012| Anyplex™Ⅱ STI-7 Detection